The surface phenotype of murine NK cells, freshly obtained from untreated mice or from mice in which spontaneous cytotoxicity has been boosted with IFN or IFN inducers such as poly(I :C) or acute virus infections, is well characterized (1-3). Although both freshly obtained splenic NK cells and in vitro cultured NK cells (1) do not express most markers present on the majority of B (sIg) or T cells (CD3 ; CD8, Lyt2; CD4, L3T4), they share with T and myelomonocytic cells other markers (asialo GM1, Thy-1, Qa-2, Qa-5, and CR3). NK cells from appropriate strains express a unique allospecific marker, NK-1.1 (4, 5) , that is restricted to NK cells (reviewed in reference 6). The murine NK cell phenotype resembles that of human NK cells. In humans the most useful marker to distinguish both freshly isolated and cultured NK cells from other lymphocytes is a low affinity receptor for the Fc portion of immune complexed IgG (CD16 or human [hu]t FcyRIII) (7). This FcyR is shared with granulocytes and macrophages (8, 9) , is antigenically and biochemically distinct from other known FcyR (10) , and allows NK cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) (11) .
Indirect evidence that murine NK cells bear FcyR is provided by data showing that: (a) removal of FcyR-bearing cells from a spleen cell population, by absorption on monolayers ofIgG-sensitized erythrocytes (EA7S), significantly reduces, although never completely abolishes, its spontaneous cytotoxicity against tumor cells (12) ; and (b) a relevant proportion of the splenic lymphocytes that form conjugates with the NK-sensitive target YAC-1 belong to the lymphocyte subset that forms rosettes with EAIgG2b (13). However, no direct evidence exists for the presence ofa defined FcyR on murine NK cells. Indeed, in one study, FcyR was not detected on cultured NK cell clones (14) .
Murine macrophages express three distinct FcyR types (15, 16) . All cell types expressing any ofthe three receptors form EA7S rosettes, and rosette formation using indicator systems sensitized with polyclonal IgG cannot distinguish among them (reviewed in reference 10). mAb 2AG2 detects an FcyR expressed at high density on mouse macrophages and, at lower density, on B and T lymphocytes (mouse [mo] Fc7RII) (17) , which binds murine IgG2b, IgGl, and IgG2a with low affinity (17) (18) (19) . Functional properties of the FcyR are inhibited by antibody 2AG2 both in vitro and in vivo (20) (21) (22) . The genes encoding moFcyRII recognized by 2AG2 have been cloned (23) (24) (25) and isolated. cDNA probes are derived from transcripts oftwo different genes, a and /3; a appears to be expressed solely in macrophages (23) . Two (3 gene transcripts, 01 and (32, have been identified. (31, and possibly (32, is expressed in 2.4G2' B and T cell lines, whereas only 02 is expressed in macrophage-like cell lines (23) .
In this paper we report direct evidence that both fresh and cultured murine NK cells express on their surface a functional FcyR recognized by antibody 2AG2. In contrast to macrophages or B and T lymphocytes, murine NK cells express only FcyRa transcripts .
Materials and Methods
Cell Lines . The murine mastocytoma P815, thymoma YAC-1, B cell lymphoma BCL,, T cell lymphomas EL-4, S49 .1, and CTLL, the macrophage-like cells P388D, and J774a, and the fibroblast L cells were maintained in culture in RPMI 1640 (Flow Laboratories, Rockville, MD) medium supplemented with 1070 FCS (Gibco Laboratories, Grand Island, NY) . All cell lines were mycoplasma-free on repeated testing . Antibodies . mAbs 2AG2 (anti-moFc RII) (17) , PK136 (anti-NK-1 .1) (5), and 3C7 (anti-IL-2R) were kindly provided by Drs . J . Unkeless (Mount Sinai Hospital, New York, NY), G . Koo (Merck, Sharp and Dohme Research Laboratories, Rahway, NJ), and T Malek (Miami University, Miami, FL), respectively. Antibody F4/80 (26) , recognizing a specific macrophage marker, was obtained from Dr. P. Witte (University of Texas, Dallas, TX) . Antibody anti-Macl (anti-CDllb) was prepared from cells obtained from the American Type Culture Collection (American Type Culture Collection, Rockville, MD) . B137 .17 is a murine IgG2a with no known antigen specificity. Polyclonal sera anti-asialo GM1 and anti-NK-2 .1 were purchased from Wako Chemicals (Dallas, TX) and kindly provided by Dr. R . Burton (University of Newcastle, Australia), respectively. The FITC-labeled mAbs anti Thy-1, anti-Lyt-1, anti-Lyt-2, anti-L3T4 and anti-I-A were kindly provided by Dr. J . Cebra (University of Pennsylvania, Philadelphia, PA) . When indicated, the antibodies were labeled with biotin or FITC according to standard procedures . The rabbit IgG anti-bovine E used to prepare EA7S and the polyclonal affinity-purified FITC-labeled goat F(ab')2 anti-murine IgM and IgG antibodies were obtained from Cooper Laboratories (Malvern, PA) . The goat anti-murine Ig used for indirect rosetting and the mouse C3H anti-DBA/2 polyclonal antibodies used for ADCC were produced in our laboratories (1, 7) .
Lymphocyte Preparations. BALB/c, C3H/He, C57BL/6, and DBA/2 mice were obtained from The Jackson Laboratories (Bar Harbor, ME) ; the (C57BL/6 x DBA/2)F, [(B6D2)Fl] hybrid mice were produced as previously described (27) . C .B-17 scid/scid (severe combined immunodeficiency, scid) mice were produced under specific pathogen free conditions at the University of Texas (Dallas, TX) . When indicated, mice were injected with poly(I :C) (Pharmacia Inc ., Piscataway, NJ), 50 ug i .p ., 24 h before they were killed . Spleens were teased and splenic lymphocytes were obtained by Ficoll/Hypaque (F/H) density gradient centrifugation (1 .092 ± 0 .001 g/ml) . When indicated, the total lymphocyte preparations were depleted of macrophages and B lymphocytes by adherence to plastic and/or direct rosetting with CrC13-treated goat anti-mouse Ig-coated sheep E and density-gradient centrifugation as previously described (7) . 2AG2' and 2 .4G2 -subsets were obtained from sIg lymphocytes by sorting on an Ortho Cytofluorograf 50H, connected to a 2100 Data Analyzer (Ortho Instruments, Westwood, MA), after sensitization with biotin-labeled 2AG2 and FITC-avidin (Vector Laboratories, Burlingame, CA) as previously described (28) . In vitro propagated NK cells were prepared as described (29, 30) . Briefly, NK-1.1' cells were selected from nylon-wool passaged and Percollfractionated (B6D2)F l mouse splenocytes using indirect immunofluorescence and FACS (FACStar ; Becton Dickinson & Co., Mountain View, CA) . NK-1.1' cells (95% pure, on FACS reanalysis) or unfractionated scid splenocytes were cultured (10 5, 106 cells/ml, respectively) at 37'C for 5-11 d in RPMI 1640 (Gibco Laboratories) supplemented with 10°70 FCS and 500 U/ml human rIL-2, generously provided by Cetus Corp. (Emeryville, CA) .
immunofluorescence and FACS The surface phenotype of the cells was detected with mAbs using direct and indirect immunofluorescence (flow cytometry) using biotin-labeled antibodies and FITC-avidin or FITC-labeled antibodies, as indicated, according to previously published procedures (31) . Fluorescence intensity was measured on either exponential or linear scales, as indicated . Two-color immunofluorescence was performed as previously described (31) using predetermined saturating concentrations of FITC-labeled antibodies and of biotin-labeled antibodies detected with phycoerythrin (PE)-labeled avidin (Becton Dickinson & Co.).
Cell-mediated Cytotoxicity. Spontaneous and antibody-dependent cytotoxicity were tested at several E/T cell ratios using 5 'Cr-labeled YAC-1 and antibody-sensitized P815 cells as target cells (104/well) in either 18-h or 4-h assays, as indicated. To quantitate cytotoxicity, lytic units (LU) were calculated on the basis oflinear regression analysis to a modified Von Grogh equation according to established methods (7) and referred to the absolute number of cells recovered. 1 LU is defined as the number of effector cells that kills 45 ,70 of the targets (LU [45 % ]) during the test period . When indicated, anti-moFcyRII and rat control isotype-matched antibodies (ascites, 1 :200 dilution) were present in the E/T cell mixture.
FcyR Functional Assay. The ability of cell surface FcyR to bind immune complexes was tested using EA7S as indicator system in rosetting assays, as previously described (8) .
FcyR mRNA Detection. To define the gene(s) encoding the FcyRII in murine NK cells, Northern blot analysis was performed on mRNA obtained from either (B6D2)Fl NK1 .1ò r C .B-17 scid NK2 .1' spleen cells that were propagated in 500 U/ml rIL-2 for 11 and 5 d, respectively. Methods for RNA preparation, fractionation in agarose gels, transfer to nylon membranes, hybridization with 12 P-labeled probes, and stripping of filters for rehybridization were as described previously (29) . RNAs were also prepared from the BCL,, EL4, and P388D, cell lines . The FcyRa+ /3 probe is a 1.0-kb Nco I restriction fragment excised from the FcyRa cDNA clone (23). This probe detects FcyRa/(31/(32 mRNA. Specific probes were obtained from the 5' portion of the FcyRa and FcyR02 cDNA clones . The a-specific probe is a 125-bp Hinf I-Alu I fragment and the /3-specific probe is a 115-bp Hinf I fragment . Each fragment contains 5'-untranslated sequences as well as the coding region for the signal peptide. cDNA probes for MHC class II I-E,fl (32) and /3-actin (33) were used as controls . Integrity and quantity ofmRNA loaded per lane (20 ug) were monitored by ethidium bromide staining of the gels and by hybridization with the /3-actin probe.
RNase Protection . A cDNA probe encoding the mouse FcyRa gene (23) was inserted into the pGEM-3 vector and used to generate uniformly-labeled antisense RNA. A 920-bp run-off transcript was generated by linearizing the cloned cDNA at the Bgl II site. Labeling and protection were performed essentially as described by the manufacturer (Promega-Biotec, Madison, WI) . Briefly, 10 t~g of total RNA from P388D,, J774a, S49 .1, L cells and the in vitro propagated NK cell populations described above were hybridized (55 0C, 16 h) to the probe in a reaction mixture that included 80% formamide, 0.4 M NaCl, and 0.04 M Pipes, pH 6.4. The unprotected RNA was digested with RNase A (34°C, 90 min) and the protected fragments were analyzed on a 5% acrylamide, 8M urea, Tris-Borate-EDTA (TBE) gel . The gel was dried and allowed to expose x-ray film for 6 h. BALB/c mice were injected with poly(I :C) 24 h before they were killed . Splenic lymphocytes were purified by density gradient centrifugation . Direct immunefluorescence was performed using FITC-labeled avidin to detect the different biotin-labeled antibodies, alone or in combination with 2AG2 . Percent positive cells, mean ± SD (three experiments) . The sIg population was purified from the total splenic lymphocytes of C57BL/6 mice by rosetting with CrCl_;-treated goat anti-mouse Ig-coated E . Direct immunofiuorescence was performed, as for BALB/c mice . Experiment representative of three performed . FcyR were detected by resetting lymphocytes with EA7S, as described in Materials and Methods, in the absence or presence of a 10 -2 dilution of the ascites of the indicated antibodies . lymphocytes in the sIg -population was reduced by >90% (Table I) . Although the proportion of 2AG2' lymphocytes was also decreased, on average 10% of the sIglymphocytes expressed FcyRII, as indicated by their reactivity with antibody 2AG2 and binding of EA7S.
The proportion of NK-1 .1' cells was similar in the total splenocyte population and in the sIg-lymphocytes . The percentage of cells positive with a combination of NK1 .1 and anti-Ig was equal to the sum of those positive with each antibody separately, suggesting that the two reagents recognize two discrete subsets of lymphocytes, NK and B cells, respectively. The proportion of cells positive with a combination of NK-1 .1 and 2AG2 antibodies was almost identical to that of the cells positive with 2AG2 antibody alone, an indication that these antibodies reacted with the same subset of cells . As is the case in total spleen cell preparations (data not shown), antibody 2AG2, but not NK-1 .1, completely inhibited EA7S rosette formation by sIg -lymphocytes . 2 .4G2 Reacts with Freshly Obtained Splenic NK Cells. To test directly whether moFcyRII is expressed on NK cells, two-color immunofluorescence experiments were performed, using 2AG2 and NK-1 .1 antibodies, with C57BL/6 splenic lymphocytes . In these lymphocyte preparations the average proportion of sIg+ and of 2AG2' cells were 53 .5 and 58 .2%, respectively. The vast majority (average 97 .7%) of sIg' lymphocytes ( Fig . 1) separated by FRCS from sIg -spleen cell preparations and the cytotoxic activity of each population was tested (Fig. 2) . Cytotoxicity mediated by the sIg' cells from BALB/c and C3H/HeN mice was 10-and 20-fold lower, respectively, than that mediated by the sIg-cells (43 and 20 LU [45%] compared with 527 and 411 LU [45%]) . The slg-/2 .4G2' cells mediated levels ofcytotoxicity similar to (BALB/c) or slightly higher (C3H/HeN) than those mediated by the total sIg -cells . On a per cell basis, spontaneous cytotoxicity mediated by slg -/2 .4G2 -cells was -50-70% lower than that mediated by either total or 2.4G2'/sIg -cells.
In Vitro Propagated NK Cells Express Functional FcyRII. NK cells, obtained from (B6D2)F1 mice and propagated in vitro with rIL-2, were tested for expression of the 2AG2 antigen . The majority of these cells maintained a cell-surface phenotype similar to that of fresh NK cells (34), i.e., Lyt-2 and L3T4-, sIg-(34), F4/80-, IL-2R(3C7) -, but low-density Thy-1' (29 and data not shown), asialo GM1' and NK-1 .1' (Fig. 3) . The TCR molecules (a, a, and ,y chains) and CD3 are not expressed in these cells (29, 30 , and data not shown) . The observation that in vitro propagated NK cell populations are F4/80-rules out the possibility that they are contaminated with macrophages expressing the 2AG2 antigen . FcyRII, as detected using antibody 2AG2, was expressed on the majority ofthese cells (Fig. 3) at a density higher than that on fresh NK cells, but reproducibly lower than that on murine macrophages or B cells (not shown). NK cells propagated in vitro were unable to bind monomeric murine IgG2a, as detected by binding of FITC-or biotin-labeled murine IgG2a B137.17 (Fig. 3) . These NK cells propagated in vitro are potent effectors of spontaneous cytotoxicity (27, and data not shown) and ADCC (Fig. 4) Antibody 2AG2 reacts with in vitro propagated murine NK cells. NK-1 .1' cells, purified by FRCS from spleens of (B6D2)F1 mice and propagated in culture in the presence of HL-2 (500 U/ml) were tested for expression of the indicated cell surface markers by indirect immunofluorescence after staining with the indicated antibody (solid line). Background fluorescence with the second antibody alone (dotted line). x-axis, intensity of fluorescence (log scale, top and middle panels ; linear scale, bottom panels); y-axis, number of cells.
assay, resulted in inhibition of the antibody-dependent killing to levels of cytotoxicity similar to those observed on non-Ab-sensitized target cells.
The FcyRII Expressedon NK Cells Is Encodedby the FcyRa Gene. To determine which ofthe FcTR genes encode the Fc7R11 polypeptide(s) expressed on the surface of NK cells, Fc7R cDNA fragments were used to probe mRNA isolated from NK1.1' cells from (B6D2)FI and from NK-2.1' cells from scid mice propagated in vitro. The mRNA transcripts in cultured (B6D2)FI splenic NK cells detected by the Fc-yRa+0 probe, i.e., the complete FcyRa cDNA that hybridizes to transcripts of both a and (3 genes (23), appear as one single band migrating faster than those in cell lines EL4 and BCLI (Fig. 5 A) . No hybridization was observed with the control CTLL cell line . EL4 and BCLI express only the FcyR01 gene, and both FcyRa and FcyRR2 RNA have higher mobility than Fc7R01 RNA (23) . FcyRa-and /3-specific cDNA fragments hybridize with RNA from the macrophage line P388Dt, producing two bands of sizes compatible with those of FcyRa and Fc7R02 transcripts, respectively (reference 23 and Fig . 5 A) . To distinguish between expression of FcyRa and Fc7RO RNA in NK cells, the specific probes were hybridized to RNA from cultured C.B-17 scid splenic NK cells (Fig . 5 B) . NK cell RNA hybridized only to the common FcyR probe and to the FcyRa-specific probe. As expected, BCLi RNA hybridized only to the common FcyR probe and to the FcyRO-specific probe. To rule out the possibility that the propagated NK cells contained macrophages expressing FcyRa transcripts, the same filter was hybridized with a cDNA probe specific for MHC class II I-E/3; no detectable class II RNA was present in the NK cell preparation (Fig. 5 B) . RNase protection assay indicates that the FcyRa transcript in NK cells is identical to that in the macrophage-like lines J774a (not shown) and P388Dt (Fig. 6 ). An antisense probe that corresponds to the a transcript, extending from the Bgl 11 site within the region encoding the EC2 domain (23) mAb 2AG2 recognizes murine FcyRII, a highly glycosylated protein migrating in SDS-PAGE as a broad band of 50-70 kD (17) , expressed on macrophages and B cells . The affinity (2 .4G2)-purified FcyRII binds murine IgGl/IgG2a/IgG2b (17, 18) and has biochemical characteristics very similar to those of the FcyR(CD16) expressed on human NK cells, neutrophilic granulocytes and macrophages (8, 9) . Thus, this antibody was used to test the hypothesis that murine NK cells bear an FcyR equivalent to the human FcyR (CD16). A small population of Thy-1+ cells that bear 2AG2 but neither sIg or I-A determinants are found in splenic lymphocytes from a variety of mouse strains. Murine NK cells express Thy-1 antigen at low density but neither CD4 (L3T4) nor CD8 (Lyt-2) (27, 29) . Our data, indicating no overlap between the 2 .4G2 +/Thy-1 + and the CD4 or CD8+ populations, are consistent with the hypothesis that the 2.4G2+/Thy-1+ cells are not T cells. The existence of this 2.4G2 +/slg-lymphocyte subset was confirmed using B cell-depleted spleen lymphocytes . The observation that CrC13-treated anti-mouse Ig-coated E do not bind to lymphocyte populations depleted of sIg+ cells by nylon wool adherence (not shown) makes it unlikely that a significant proportion of NK cells are lost, using this procedure, in the B cell rosetting population. The 2.4G2 +/slg-subset purified in this way is unlikely to represent sIg -B cells or macrophages, because it lacks expression of MHC class II determinants and it is present in spleen cell preparations depleted of macrophages by adherence to plastic . The identification of the sIg -/2.4G2+ cells as NK cells is supported by the fact that, in C57BL/6 spleen, the 2.4G2 +/slg-cell subset coexpresses the NK-specific antigen NK-1. 1 . Nonspecific binding of antibody NK-1.1 to the FcyR of 2AG2 + cells through its Fe portion is excluded because antibody NK-1.1 does not inhibit EA7S rosette formation by either total or slg-cells and does not bind to spleen lymphocyte preparations from BALB/c mice that do not express NK-1 .1 alloantigen but express FcyR and 2AG2 determinant (data not shown) . Although we did not use F(ab')2 fragments of antibody 2AG2, it is unlikely that the antibody binds to FcR on the positive cells through its Fc portion because all experiments have been performed in the presence of excess human IgG, previously shown to block nonspecific Fc binding .
The 2.4G2 +/sIg-cells mediate higher levels of spontaneous cytotoxicity, on a per cell basis, than the sIg -/2 .4G2 -cells. However, the absolute number of LU recovered in the two populations is not significantly different. Several possibilities may explain these results . Similar functional consequences occur in human NK cells upon FcyR(CD16) interaction with anti-FcyR(CD16) antibodies and immune complexes (35) . Low spontaneous cytotoxicity in murine 2AG2+ cells may reflect downmodulation of this activity induced by the interaction of FcyR with anti-FcyR anti-bodies, similar to that previously reported with both human (36) and mouse cells (12) . Also, 2.4G2 -NK cells might exist, in analogy with the small proportion of human NK cells that reportedly do not express Fc7R(CD16) (37). However, our inability to recover all spontaneous cytotoxicity in 2AG2+ cells is most likely due to the low density with which this epitope is expressed and the insufficient sensitivity of available separation techniques to completely deplete the cells expressing the antigen at the lowest density.
The low density expression of the FcyR detected by 2AG2 on murine NK cells was confirmed using highly homogeneous NK-1. Our data provide the first direct evidence that a single FcyRII RNA transcript is expressed in murine NK cells and that the FcyRIIa transcripts present in NK cells are identical to those present in macrophages. These data suggest that the FcyR expressed in murine NK cells is encoded by the FcyRIIa gene.
Antibody 2AG2 reacts with the extracellular domain of any of the proteins encoded by FcyRII genes (19) and our data show that the epitope detected by 2AG2 is responsible for FcyR-dependent functions also on these cells, as previously reported in macrophages (19) . Although FcyRII molecules encoded by the different genes appear to bind IgG with the same specificity, a correlation exists, within the 2.4G2+ cell types tested, between expression of the FcyRIIa gene and ability to mediate ADCC. Recent data (Kuziel, W., and P W. Tucker, manuscript in preparation) indicate that FcyRIIa transcripts are also uniquely expressed in a TCR-y/S+ subset of murine dendritic epidermal cells (38) able to mediate ADCC. Although the extracellular domains of the FcyR are similar, the transmembrane and cytoplasmic domains of the FcyRa-encoded protein bear no homology with the respective domains of the Fc-yRol or R2-encoded proteins (23). The apparent requirement for an FcyRa-encoded receptor for ADCC activity suggests that features of these two domains may be responsible for this FcyR-mediated function, possibly via a role in signal transduction . The observation that only FcyRa transcripts are detectable in NK cells, as opposed to (31 transcripts in lymphocyte tumor lines and both the a and (32 transcripts in macrophages, may also bear on the lineage to which these cells belong .
A gene encoding huFcyR(CD16), the only type of FcyR expressed on human NK cells, has been cloned recently from a human placenta cDNA library (39) and reported to have the greatest sequence homology with the moFc7Ru cDNA . The homology between the two genes extends throughout the transmembrane portion of the molecule, bearing no or minimal homology, in this portion ofthe molecule, to the other FcyR types defined at present. In human neutrophils, FcyR(CD16) lacks an intracytoplasmic domain and is anchored to the membrane through glycosylphosphatidyl inositol (GPI) (39, 40) . In contrast to the GPI-linked form in granulocytes, a transmembrane form of FcyR(CD16) exists : macrophages from patients affected with paroxysmal nocturnal hemoglobinuria, who have an impaired ability to form GPI anchors (41) , express FcyR(CD16). Furthermore, FcyR(CD16) on both fresh and cultured human NK cells and FcyRII on murine NK cells are insensitive to doses of PI-specific phospholipase C (PI-PLC), which cleaves 90% of the FcyR(CD16) on both fresh and cultured granulocytes, the CD14 on monocytes, and the Thy-1 on murine T cells (reference 42 and data not shown). Two nearly identical, linked genes for huFc7R111(CD16) have been cloned and sequenced (42) . These genes (111-1 and III-2) are transcribed in a cell type-specific fashion to generate the two alternatively anchored forms of the receptor on neutrophils and NK cells . The FcyRIII(CD16) sequence for the NK cells molecule encodes a transmembrane protein and demonstrates homology with the moFcyR1Ia molecule, not only in its transmembrane domain but in its cytoplasmic domain as well. Therefore, the moFc-YR11 encoded by the Fc-yR1Ia gene in murine NK cells is the equivalent of the FcyR(CD16) on human NK cells . 
